Logo
Dhritiman @go_66fa526292b75
In Silico Clinical Trials: The Future of Drug Development

Reduced Risks for Trial Participants

Since In silico clinical trials do not directly involve human subjects, they eliminate health and safety risks that participants may otherwise face in traditional clinical research. New drugs can be tested on virtual human physiology models to identify potential adverse reactions or undesirable outcomes before exposing any real people to the candidate molecules. This enhances patient protections in drug development.

Personalized Medicine Applications

Overview of In silico trials also enable testing of drugs on personalized virtual models tailored for specific patient populations defined by age, gender, genetics, medical conditions etc.

https://www.zupyak.com/p/4...
7 days ago (E)

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Dhritiman , click on at the bottom under it